Complications of intrathecal baclofen pump therapy in pediatric patients

Journal of Pediatric Orthopaedics

Volumn 30, Issue 1, 2010, Pages 76-81

  Borowski, Andrzej ^a,b   Littleton, Aaron G ^a   Borkhuu, Battugs ^a   Presedo, Ana ^a   Shah, Suken ^a   Dabney, Kirk W ^a   Lyons, Sharon ^a   McMannus, Maura ^a   Miller, Freeman ^a  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Cerebral palsy; Complications; Infection; Intrathecal baclofen therapy

Indexed keywords

BACLOFEN;

ACUTE PUMP FAILURE; CATHETER BREAK; CATHETER COMPLICATION; CATHETER DISCONNECTION; CATHETER MALFUNCTION; CEREBRAL PALSY; CHILD; CHILD DEATH; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FOLLOW UP; HUMAN; HYPERMOBILITY; INCIDENCE; INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SKIN IRRITATION; SPINE FUSION; TREATMENT PLANNING; WOUND DEHISCENCE;

ADOLESCENT; BACLOFEN; CEREBRAL PALSY; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFECTION; INFUSION PUMPS, IMPLANTABLE; MALE; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; POSTOPERATIVE COMPLICATIONS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 76149101269     PISSN: 02716798     EISSN: None     Source Type: Journal    
DOI: 10.1097/BPO.0b013e3181c6b257     Document Type: Review

References (24)

1. Miller F. Cerebral Palsy. New York: Springer Science Business Media; 2005.
2. Gerszten PC, Albright AL, Johnstone GF. Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy. J Neurosurg. 1998;88:1009-1013.
3. Awaad Y, Tayem H, Munoz S, et al.. Functional assessment following intrathecal baclofen therapy in children with spastic cerebral palsy. J Child Neurol. 2003;18:26-34.
4. Campbell WM, Ferrel A, McLaughlin JF, et al.. Long-term safety and efficacy of continuous intrathecal baclofen. Dev Med Child Neurol. 2002;44:660-1605
5. Zahavi A, Geertzen JH, Middel B, et al.. Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin. J Neurol Neurosurg Psychiatry. 2004;75:1553-1557.
6. Penn RD, Kroin JS. Continuous intrathecal baclofen for severe spasticity. Lancet. 1985;20:125-127.
7. Penn RD, Savoy SM, Corcos D, et al.. Intrathecal baclofen for severe spinal spasticity. N Engl J Med. 1989;320:1517-1521. (Pubitemid 19145803)
8. Albright AL. Baclofen in the treatment of cerebral palsy. J Child Neurol. 1996;11:77-83.
9. Albright AL, Barron WB, Fasick MP, et al.. Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA. 1993; 270:2475-2477.
10. Campbell SK, Almeida GL, Penn RD, et al.. The effects of intrathecally administered baclofen on function in patients with spasticity. Phys Ther. 1995;75:352-362.
11. Murphy NA, Irwin MC, Hoff C. Intrathecal baclofen therapy in children with cerebral palsy: efficacy and complications. Arch Phys Med Rehabil. 2002;83:1721-1725.
12. Palisano R, Rosenbaum P, Walter S, et al.. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997;39:214-223.
13. Borowski A, Shah SA, Littleton AG, et al.. Baclofen pump implantation and spinal fusion in children techniques and complications. Spine. 2008;33:1995-2000.
14. Albright AL, Cervi A, Singletary J. Intrathecal baclofen for spasticity in cerebral palsy. JAMA. 1991;265:1418-1422.
15. Gerszten PC, Albright AL, Barry MJ. Effect on ambulation of continuous intrathecal baclofen infusion. Pediatr Neurosurg. 1997; 27:40-44.
16. Gooch JL, Oberg WA, Grams B, et al.. Complications of intrathecal baclofen pumps in children. Pediatr Neurosurg. 2003;39:1-6.
17. Krach LE, Nettleton A, Klempka B. Satisfaction of individuals treated long-term with continuous infusion of intrathecal baclofen by implanted programmable pump. Pediatr Rehabil. 2006;9:210-218.
18. Albright AL, Awaad Y, Muhonen M, et al.. Performance and complications associated with the synchromed 10-mL infusion pump for intrathecal baclofen administration in children. J Neurosurg. 2004;101(1 suppl):64-68.
19. Gilmartin R, Bruce D, Storrs BB, et al.. Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial. J Child Neurol. 2000;15:71-77.
20. Gooch JL, Oberg WA, Grams B, et al.. Care provider assessment of intrathecal baclofen in children. Dev Med Child Neurol. 2004;46: 548-552.
21. Vender JR, Hester S, Rekito A, et al.. Baclofen intrathecal pumps delivery systems. Contemp Neurosurg. 2005;27:1-7.
22. Vender JR, Hester S, Waller JL, et al.. Identification and management of intrathecal baclofen pump complications: a comparison of pediatric and adult patients. J Neurosurg. 2006; 104(1 suppl):9-15.
23. Boviatsis EJ, Kouyialis AT, Boutsikakis I, et al.. Infected CNS infusion pumps. Is there a chance for treatment without removal? Acta Neurochir (Wien). 2004;146:463-467.
24. Kopell BH, Sala D, Doyle WK, et al.. Subfascial implantation of intrathecal baclofen pumps in children: technical note. Neurosurgery. 2001;49:753-756; discussion 756-757.